PRASUN JALAL to United States
This is a "connection" page, showing publications PRASUN JALAL has written about United States.
Connection Strength
0.151
-
Survival and Causes of Death among Patients with Intrahepatic Cholangiocarcinoma in the United States from 2000 to 2018. Cancer Epidemiol Biomarkers Prev. 2022 Dec 05; 31(12):2169-2176.
Score: 0.065
-
Long-term outcomes and trends in liver transplantation for hereditary hemochromatosis in the United States. Liver Transpl. 2023 01 01; 29(1):15-25.
Score: 0.016
-
Significant improvements, but consistent disparities in survival for African Americans after liver transplantation. Clin Transplant. 2022 06; 36(6):e14646.
Score: 0.015
-
Impact of COVID-19 Pandemic on Liver Transplantation and Alcohol-Associated Liver Disease in the USA. Hepatology. 2021 12; 74(6):3316-3329.
Score: 0.015
-
Association of dietary fat intake and hepatocellular carcinoma among US adults. Cancer Med. 2021 10; 10(20):7308-7319.
Score: 0.015
-
Posttransplant Outcome of Lean Compared With Obese Nonalcoholic Steatohepatitis in the United States: The Obesity Paradox. Liver Transpl. 2020 01; 26(1):68-79.
Score: 0.013
-
Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study. Gastroenterology. 2019 05; 156(6):1683-1692.e1.
Score: 0.012